Cas 915770-52-4,Benzamide, 3-(benzo[b]thien-5-yloxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-[(1S)-1-methyl- 2-[[tris(1-methylethyl)silyl]oxy]ethoxy]-

915770-52-4

Post Buying Request

Basic information

Product Name: Benzamide, 3-(benzo[b]thien-5-yloxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-[(1S)-1-methyl- 2-[[tris(1-methylethyl)silyl]oxy]ethoxy]-
Synonyms:
CAS NO:915770-52-4
Molecular Formula: C31H41N3O4SSi
Molecular Weight: 579.836
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Benzamide, 3-(benzo[b]thien-5-yloxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-[(1S)-1-methyl- 2-[[tris(1-methylethyl)silyl]oxy]ethoxy]-(CAS DataBase Reference)
NIST Chemistry Reference: Benzamide, 3-(benzo[b]thien-5-yloxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-[(1S)-1-methyl- 2-[[tris(1-methylethyl)silyl]oxy]ethoxy]-(915770-52-4)
EPA Substance Registry System: Benzamide, 3-(benzo[b]thien-5-yloxy)-N-(1-methyl-1H-pyrazol-3-yl)-5-[(1S)-1-methyl- 2-[[tris(1-methylethyl)silyl]oxy]ethoxy]-(915770-52-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 915770-52-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

915770-52-4 Suppliers

Recommended suppliers

915770-52-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 915770-52-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,7,7 and 0 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 915770-52:
(8*9)+(7*1)+(6*5)+(5*7)+(4*7)+(3*0)+(2*5)+(1*2)=184
184 % 10 = 4
So 915770-52-4 is a valid CAS Registry Number.

915770-52-4Upstream product

915770-52-4Downstream Products

915770-52-4Relevant academic research and scientific papers

HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES

-

Page/Page column 65, (2008/06/13)

Compounds of formula (I), wherein R1, R4, HET-1 and HET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 915770-52-4